Eton Pharmaceuticals, Inc. financial data

Symbol
ETON on Nasdaq
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181 % +18.1%
Quick Ratio 54.3 % +421%
Debt-to-equity 282 % +144%
Return On Equity -27.9 % +23.3%
Return On Assets -7.3 % +56.7%
Operating Margin -3.81 % +74.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.8M shares +3.8%
Common Stock, Shares, Outstanding 26.8M shares +3.8%
Entity Public Float 80.2M USD -5.31%
Common Stock, Value, Issued 27K USD +3.85%
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +3.83%
Weighted Average Number of Shares Outstanding, Diluted 26.9M shares +1.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 70.3M USD +103%
Research and Development Expense 5.11M USD -1.14%
General and Administrative Expense 33.7M USD +63.4%
Operating Income (Loss) -2.68M USD +48.7%
Nonoperating Income (Expense) -1.21M USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.48M USD -22.2%
Income Tax Expense (Benefit) 199K USD +13.7%
Net Income (Loss) Attributable to Parent -6.68M USD -21.9%
Earnings Per Share, Basic 0 USD/shares -8.7%
Earnings Per Share, Diluted -0.07 USD/shares -450%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.1M USD +83.2%
Accounts Receivable, after Allowance for Credit Loss, Current 13.1M USD +134%
Inventory, Net 16.9M USD +770%
Assets, Current 72M USD +142%
Property, Plant and Equipment, Net 294K USD +791%
Operating Lease, Right-of-Use Asset 319K USD +65.3%
Intangible Assets, Net (Excluding Goodwill) 31.9M USD +445%
Other Assets, Noncurrent 19K USD +58.3%
Assets 105M USD +192%
Accounts Payable, Current 14.3M USD +431%
Accrued Liabilities, Current 9.12M USD
Liabilities, Current 44.2M USD +124%
Operating Lease, Liability, Noncurrent 480K USD +281%
Other Liabilities, Noncurrent 3.94M USD
Liabilities 81.4M USD +310%
Retained Earnings (Accumulated Deficit) -114M USD -6.23%
Stockholders' Equity Attributable to Parent 23.1M USD +44.7%
Liabilities and Equity 105M USD +192%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.09M USD
Net Cash Provided by (Used in) Financing Activities 394K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 26.8M shares +3.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.48M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 642K USD +238%
Deferred Tax Assets, Valuation Allowance 20.6M USD -4.31%
Deferred Tax Assets, Gross 21M USD -3.19%
Operating Lease, Liability 510K USD +154%
Depreciation 48K USD +6.67%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 725K USD +222%
Property, Plant and Equipment, Gross 480K USD +5.96%
Operating Lease, Liability, Current 30K USD -60%
Lessee, Operating Lease, Liability, to be Paid, Year Two 127K USD +41.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 22K USD -75.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 215K USD +796%
Lessee, Operating Lease, Liability, to be Paid, Year Three 135K USD +487%
Deferred Tax Assets, Operating Loss Carryforwards 14.1M USD -8.43%
Unrecognized Tax Benefits 382K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD
Operating Lease, Payments 23K USD +130%
Additional Paid in Capital 137M USD
Amortization of Intangible Assets 1.88M USD +126%
Deferred Tax Assets, Net of Valuation Allowance 404K USD +139%
Share-based Payment Arrangement, Expense 1.2M USD +46.2%
Interest Expense 1.21M USD +474%